A CD68-expressing tissue-homing subset in peripheral CD8+ T cells predicts response to anti-PD-1 therapy in lung cancer
- 1Department of Laboratory Medicine, Infectious Diseases and Pathogen Biology Center, The First Hospital of Jilin University
Abstract
Background: T-cell function is regulated by immunometabolism, and lysosomes are signaling hubs. CD68 (LAMP4), traditionally regarded as a monocyte/macrophage marker, has been largely neglected in T cell biology. We aimed to assess the link between CD68 expression in T cells and anti-PD-1 response in lung cancer, and its potential as an early dynamic biomarker in peripheral blood CD8 ⁺ T cells.
Methods: We analyzed transcriptomic (GSE126044, GSE135222, GSE166449) and single-cell (GSE207422) data from anti-PD-1-treated lung cancer cohorts to identify lysosome related pathways and key genes, validated with peripheral blood CD8 ⁺ T cell data (GSE111414). Prospectively, we enrolled lung cancer patients receiving anti-PD-1 therapy, collecting peripheral blood at baseline and week 3. Flow cytometry measured CD68 in CD8 ⁺ T cells and subsets, assessing association with response, progression-free survival (PFS), and functional markers (granzyme B, perforin, Ki-67, CD69, IFN-γ, IL-1β).
Results: Responders showed enrichment of lysosome pathways and upregulation of 8 lysosome related genes including CD68, positively correlated with monocyte and T cell infiltration. Single-cell data linked CD68 expression in T cell to favorable response. After one cycle, the proportion of CD8 ⁺ CD68 ⁺ T cells was lower in non-responders ( P<0.05 ), with AUC 0.803 ( P=0.044 ) and cutoff 1.015%, stratifying PFS ( P=0.0225 ). CD68 was highest in naïve T cells at baseline, but decreased across subsets after treatment in non-responders (all P<0.01 ). Functionally, compared with CD8 ⁺ CD68 ⁻ T cells, CD8 ⁺ CD68 ⁺ T cells exhibited lower expression of granzyme B and perforin but higher expression of Ki-67, CD69, IFN-γ, and IL-1β (all P<0.001 ), suggesting a CD8 ⁺ T cell state characterized by lower cytotoxicity and enhanced proliferative and cytokine producing capacities, accompanied by a tissue residency associated phenotype.
Conclusion: CD8 ⁺ CD68 ⁺ T cells exhibit lower cytotoxicity but greater proliferative and cytokine producing capacities, together with a tissue residency associated phenotype, suggesting a precursor-like state. Low CD68 expression in tumor-infiltrating T cells and the post-treatment reduction of CD68 expression in peripheral blood CD8 ⁺ T cells are associated with resistance to anti-PD-1 therapy in lung cancer. These findings suggest that CD8 ⁺ CD68 ⁺ T cells may serve as a potential early dynamic immune biomarker for monitoring and assessing response to anti-PD-1 therapy in lung cancer.
Related
- The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.
- Pan-Cancer Gene Expression Predicts Per-Cancer Radiation Therapy Response
- From revascularization to multimodal integrated therapy for peripheral arterial disease: immunomodulation, metabolic correction, and tissue engineering
- Aging, HIV Status, and Sex Differentially Influence Antiretroviral Therapy Disposition Pathways in Rectosigmoid Tissue and Peripheral Blood Mononuclear Cells
- Hypoxic Burden Predicts Symptomatic but Not Sleep Architecture Response to CPAP Therapy in Obstructive Sleep Apnea
BibTeX
@article{wang2026cd68expressing,
title = {{A CD68-expressing tissue-homing subset in peripheral CD8+ T cells predicts response to anti-PD-1 therapy in lung cancer}},
author = {Ying Wang and Jing Huang and Zhengyi Sun and Yumei Pei and Jiancheng Xu},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1995008},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1995008/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A CD68-expressing tissue-homing subset in peripheral CD8+ T cells predicts response to anti-PD-1 therapy in lung cancer
AU - Ying Wang
AU - Jing Huang
AU - Zhengyi Sun
AU - Yumei Pei
AU - Jiancheng Xu
PY - 2026
DA - 2026/10/13
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1995008
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1995008/full
AB - Background: T-cell function is regulated by immunometabolism, and lysosomes are signaling hubs. CD68 (LAMP4), traditionally regarded as a monocyte/macrophage marker, has been largely neglected in T cell biology. We aimed to assess the link between CD68 expression in T cells and anti-PD-1 response in lung cancer, and its potential as an early dynamic biomarker in peripheral blood CD8 ⁺ T cells. Methods: We analyzed transcriptomic (GSE126044, GSE135222, GSE166449) and single-cell (GSE207422) data from anti-PD-1-treated lung cancer cohorts to identify lysosome related pathways and key genes, validated with peripheral blood CD8 ⁺ T cell data (GSE111414). Prospectively, we enrolled lung cancer patients receiving anti-PD-1 therapy, collecting peripheral blood at baseline and week 3. Flow cytometry measured CD68 in CD8 ⁺ T cells and subsets, assessing association with response, progression-free survival (PFS), and functional markers (granzyme B, perforin, Ki-67, CD69, IFN-γ, IL-1β). Results: Responders showed enrichment of lysosome pathways and upregulation of 8 lysosome related genes including CD68, positively correlated with monocyte and T cell infiltration. Single-cell data linked CD68 expression in T cell to favorable response. After one cycle, the proportion of CD8 ⁺ CD68 ⁺ T cells was lower in non-responders ( P<0.05 ), with AUC 0.803 ( P=0.044 ) and cutoff 1.015%, stratifying PFS ( P=0.0225 ). CD68 was highest in naïve T cells at baseline, but decreased across subsets after treatment in non-responders (all P<0.01 ). Functionally, compared with CD8 ⁺ CD68 ⁻ T cells, CD8 ⁺ CD68 ⁺ T cells exhibited lower expression of granzyme B and perforin but higher expression of Ki-67, CD69, IFN-γ, and IL-1β (all P<0.001 ), suggesting a CD8 ⁺ T cell state characterized by lower cytotoxicity and enhanced proliferative and cytokine producing capacities, accompanied by a tissue residency associated phenotype. Conclusion: CD8 ⁺ CD68 ⁺ T cells exhibit lower cytotoxicity but greater proliferative and cytokine producing capacities, together with a tissue residency associated phenotype, suggesting a precursor-like state. Low CD68 expression in tumor-infiltrating T cells and the post-treatment reduction of CD68 expression in peripheral blood CD8 ⁺ T cells are associated with resistance to anti-PD-1 therapy in lung cancer. These findings suggest that CD8 ⁺ CD68 ⁺ T cells may serve as a potential early dynamic immune biomarker for monitoring and assessing response to anti-PD-1 therapy in lung cancer.
SN - 1664-3224
ER -